期刊文献+

感染后咳嗽中医诊疗方案建立与评价的思路探讨 被引量:12

Investigation on establishment and evaluation of TCM diagnosis and treatment protocols of post infectious cough
原文传递
导出
摘要 通过对感染后咳嗽中医诊疗的现状和问题进行分析,探讨了感染后咳嗽中医诊疗方案建立与评价的方法和思路,提出方案的建立与评价应确立便于推广的中医辨证规范,优化精简中医治疗方案,确立不同医院适用的西医诊断标准,选择科学、公认的疗效评价指标,从而提高感染后咳嗽的中医诊疗水平,提高临床研究质量。 To investigate the establishment and evaluation of TCM diagnosis and treatment protocols of post infectious cough based on its status and problems. It will make the TCM syndrome standardization easy to popularize,and realize the optimization and simplification of TCM treatment protocols,establishment of western medicine diagnostic criteria beseem different hospital,and selection of scientific and accepted outcome measurements,to improve level of TCM diagnosis and treatment of post infectious cough and quality of its clinical research.
出处 《中华中医药杂志》 CAS CSCD 北大核心 2010年第6期888-890,共3页 China Journal of Traditional Chinese Medicine and Pharmacy
基金 "十一五"国家科技支撑计划(No.2007BAI20B086)~~
关键词 感染后咳嗽 中医诊疗方案 探讨 Post infectious cough TCM diagnosis and treatment program Investigation
  • 相关文献

参考文献8

二级参考文献39

  • 1刘春丽,赖克方,陈如冲,罗炜,曾运祥,姚卫民,钟南山.胃食管反流性咳嗽患者气道黏膜与分泌物中神经肽含量的变化[J].中华结核和呼吸杂志,2005,28(8):520-524. 被引量:34
  • 2罗炜,赖克方,陈如冲,刘春丽,曾运祥,钟淑卿,李德容,吴华,何梦璋,钟南山.嗜酸粒细胞性支气管炎患者气道炎症细胞及介质特征的探讨[J].中华结核和呼吸杂志,2005,28(9):626-629. 被引量:64
  • 3陈如冲,赖克方,刘春丽,罗炜,郑劲平,钟南山.辣椒素咳嗽激发试验方法的建立及其安全性评价[J].中华结核和呼吸杂志,2005,28(11):751-754. 被引量:39
  • 4Inwin RS, Boulet LP, Cloulies MM, et al. Managing cough as a defense mechanism and as a symptoms. Chest, 1998, 114 (2Suppl) : 133S.
  • 5Irwin RS, Madison JM. The diagnosis and treatment of cough.New Engl J Med,2000,343(23):1715-1721.
  • 6McGarvey LAP. Which inveotigations are most useful in th diaenosis of chronic cough?. Thorax, 2004,59 (4) : 342-346.
  • 7Morice AH. The diagnos-is and management of chronic cough. Eur Respir J ,2004,24(3) :481-492.
  • 8Belridi MG, Geppetti P. Current and future drugs for the treatment of chronic cough. Thorax, 2004,59 (5) : 438-440.
  • 9Maice AH, Kastelik JA. Chronic cough in adults. Thorax, 2003,58(10) : 901-907.
  • 10Psaty BM, Weiss NS, Furberg CD, et al. Surrogate end points, health outcomes and the drug-approval process for the treatment of risk factors for cardiovascular disease. JAMA.1999 ;282(8): 786-790.

共引文献1663

同被引文献110

引证文献12

二级引证文献50

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部